COVID Testing Expands to Albany International Airport

qbinc, Author at Quadrant Biosciences

COVID Testing Expands to Albany International Airport

Since December, the Albany International Airport has been offering covid testing to all travellers and staff at the airport. The test, called the Clarifi COVID-19 Test Kit, was co-developed by Quadrant Biosciences and SUNY Upstate Medical University in Syracuse, and has been used to test over a half million students and faculty at SUNY colleges

Read More...

Governor Cuomo Recognizes Clarifi COVID-19 Test Kit as Most Sensitive Saliva Test

This past December, the United States Food and Drug Administration (FDA) ranked the Clarifi COVID-19 Test Kit as the most sensitive COVID-19 saliva test currently available on the market.  In a statement released by the office of Governor Andrew Cuomo, the Governor congratulated Quadrant Biosciences and SUNY Upstate Medical for our work developing the Clarifi

Read More...

Quadrant Biosciences Receives “Project of the Year” Award

Quadrant Biosciences and SUNY Upstate Medical University have been chosen as recipients of MedTech’s 2020 Project of the Year award for the development of the Clarifi COVID-19 saliva test. The award recognizes an initiative that has had a “singular and demonstrable positive impact on public health.” The Clarifi COVID-19 saliva test was co-developed by Quadrant

Read More...

Saliva May Be the Key to Concussion Diagnosis

Could saliva be the key to concussion diagnosis and management?  Scientists say yes, according to the study “Diagnosing Mild Traumatic Brain Injury Using Saliva RNA Compared to Cognitive and Balance Testing,” published in Clinical and Translational Medicine. Researchers from Quadrant Biosciences, Penn State College of Medicine, SUNY Buffalo Jacobs School of Medicine, and SUNY Medical

Read More...

New York Gov Cuomo Announces COVID-19 Testing Program

Over the past six months, Quadrant Biosciences has been working in collaboration with New York State to develop and implement several COVID-19 detection projects. These include a program to detect the SARS-CoV-2 RNA virus in wastewater, and a pooled testing program for New York colleges.  In a recent press release, Governor Cuomo announced these new

Read More...

Quadrant Biosciences Receives CPT® PLA Code

Our company has successfully received a CPT® Proprietary Laboratory Analyses (PLA) Code from the American Medical Association for our autism saliva test, Clarifi ASD. This PLA code officially became effective on April 1, 2020.  Attaining this alpha-numeric CPT code marks a step forward in the reimbursement process for families interested in the Clarifi autism saliva test.

Read More...

Quadrant Biosciences Developing Saliva Swab for COVID-19

We’re excited to share that our company has been working on a new, rapid diagnostic test for COVID-19. Once again, we’ve partnered with researchers at SUNY Upstate Medical University to develop this saliva-based RNA assay.  As you know, we have developed the world’s first epigenetic saliva test for autism called Clarifi™ ASD. When the COVID-19

Read More...

Quadrant Biosciences Offers Common Shares of the Company

We’re excited to share a new opportunity for investors looking to help improve the lives of  families across the country.  Quadrant Biosciences is now offering common shares to the general public through the equity crowdfunding platform, Wefunder.  This campaign is the first time Quadrant is offering shares to the public at large, however we’ve previously

Read More...

Quadrant Biosciences Returns to Autism Live

Last week, we had the great privilege of being invited back on Autism Live. During the webshow, we were able to discuss the recent launch of our autism saliva test, Clarifi ASD (some of you may recall our segment on the show last spring). Autism Live is an interactive web show hosted by Shannon Penrod,

Read More...